好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2015 Annual Meeting | 3FC.001 - Dementia Overview

Monday 04/20/15
08:00 AM - 05:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Full-Day Course
John C. Morris, MD, FAAN
Participants should be familiar with the differential diagnosis of dementia; recognize the clinical features and practical approaches of the different dementias; understand the basis for amyloid and/or tau as a therapeutic target in Alzheimer's disease; the molecular basis of different dementias; and the genetic components of the dementias.
7.50 CME credits
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Trainee, General Neurologist, Specialist Neurologist
Case-based, Didactic
Event Timeline
08:00 AM - 09:00 AM Clinical Diagnosis of Alzheimer's Disease Incorporating Biomarkers
John C. Morris, MD, FAAN
09:00 AM - 09:55 AM Neuropsychological Evaluation to Aid in Dementia Diagnosis
Jennifer J. Manly, PhD
09:55 AM - 10:10 AM Break
10:10 AM - 11:05 AM Neuroimaging to Aid in Dementia Diagnosis
Eric M. McDade, DO
11:05 AM - 12:00 PM Non-Alzheimer Dementias
Brandy R. Matthews, MD, FAAN
12:00 PM - 01:00 PM Break
01:00 PM - 01:55 PM Rapidly Progressive Dementias
Beau M. Ances, MD, PhD, MS, FAAN
01:55 PM - 02:50 PM Chronic Traumatic Encephalopathy/Traumatic Brain Injury
Ann C. McKee, MD
02:50 PM - 03:05 PM Break
03:05 PM - 04:00 PM Pathobiology and Genetics of Alzheimer's Disease
David M. Holtzman, MD, FAAN
04:00 PM - 05:00 PM Dementia Therapy
Steven E. Arnold, MD
Faculty Disclosures
John C. Morris, MD, FAAN Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CBR International Advisory Board. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cure Alzheimers Fund. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LEADS Steering Commitee. The institution of Dr. Morris has received research support from NIH grants. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care.
Brandy R. Matthews, MD, FAAN No disclosure on file
Jennifer J. Manly, PhD The institution of Dr. Manly has received research support from NIH. Dr. Manly has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with University of Mississippi.
Eric M. McDade, DO Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. McDade has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzamend. Dr. McDade has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fondation Alzheimer. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. The institution of Dr. McDade has received research support from NIA. The institution of Dr. McDade has received research support from Eli Lilly. The institution of Dr. McDade has received research support from Hoffman-La Roche. The institution of Dr. McDade has received research support from Eisai. The institution of Dr. McDade has received research support from Eisai. Dr. McDade has received intellectual property interests from a discovery or technology relating to health care. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Fondation Alzheimer.
Beau M. Ances, MD, PhD, MS, FAAN Dr. Ances has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Ances has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Kinnard Lawyers.
David M. Holtzman, MD, FAAN No disclosure on file
Steven E. Arnold, MD Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EIP Pharma. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sage Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cortexyme. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Boyle Shaughnessy Law. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wolf Greenfield. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Bob's Last Marathon.
Ann C. McKee, MD Dr. McKee has nothing to disclose.